Pulmonx Corp. (LUNG)
1.99
-0.09
(-4.33%)
USD |
NASDAQ |
Sep 09, 16:00
1.99
0.00 (0.00%)
After-Hours: 16:07
Pulmonx EPS Diluted (Quarterly) : -0.2374 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2374 |
| March 31, 2026 | -0.3259 |
| December 31, 2025 | -0.2518 |
| September 30, 2025 | -0.3409 |
| June 30, 2025 | -0.3753 |
| March 31, 2025 | -0.3616 |
| December 31, 2024 | -0.3329 |
| September 30, 2024 | -0.3601 |
| June 30, 2024 | -0.3936 |
| March 31, 2024 | -0.3559 |
| December 31, 2023 | -0.3619 |
| September 30, 2023 | -0.3909 |
| June 30, 2023 | -0.4282 |
| March 31, 2023 | -0.4221 |
| December 31, 2022 | -0.3821 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.3811 |
| June 30, 2022 | -0.3956 |
| March 31, 2022 | -0.43 |
| December 31, 2021 | -0.355 |
| September 30, 2021 | -0.2793 |
| June 30, 2021 | -0.3596 |
| March 31, 2021 | -0.3537 |
| December 31, 2020 | -0.2741 |
| September 30, 2020 | -0.1082 |
| June 30, 2020 | -0.3362 |
| March 31, 2020 | -0.2022 |
| December 31, 2019 | -0.1318 |
| September 30, 2019 | -0.1224 |
| June 30, 2019 | -0.1573 |
| March 31, 2019 | -0.173 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.2735 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
| Baxter International, Inc. | 0.2432 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.08M |
| Revenue (Quarterly) | 22.76M |
| Total Expenses (Quarterly) | 32.84M |
| Enterprise Value | 89.44M |
| Gross Profit Margin (Quarterly) | 77.53% |
| Profit Margin (Quarterly) | -44.30% |
| Earnings Yield | -58.09% |
| Normalized Earnings Yield | -58.09 |